Synthesis and structure-activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3-d]pyrimidine derivatives

被引：21

作者：

Han, Fangbin ^{[1
]}

Lin, Songwen ^{[1
]}

Liu, Peng ^{[1
]}

Tao, Jing ^{[1
]}

Yi, Chongqin ^{[1
]}

Xu, Heng ^{[1
]}

机构：

[1] PKUCare Pharmaceut R&D Ctr, Biotech Innovat Works, Beijing 102206, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 18期

基金：

中国博士后科学基金;

关键词：

Phosphoinositide; 3-kinase; Mammalian target of rapamycin; Dual inhibitor; Anti-tumor activity; ANTITUMOR-ACTIVITY; HUMAN CANCER; CLASS-I; POTENT; DISCOVERY; TARGET; RAPAMYCIN; PI3K; PATHWAY; MTOR;

D O I：

10.1016/j.bmcl.2014.07.073

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway by PI3K/mTOR dual inhibitors provides a promising new approach to the treatment of cancers. In this Letter, we identified structurally novel and potent PI3K/ mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3-d] pyrimidine derivatives. Their synthesis and structure-activity relationships are reported. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：4538 / 4541

页数：4

共 50 条

[1] Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors
Hamby, JM
Connolly, CJC
Schroeder, MC
Winters, RT
Showalter, HDH
Panek, RL
Major, TC
Olsewski, B
Ryan, MJ
Dahring, T
Lu, GH
Keiser, J
Amar, A
Shen, C
Kraker, AJ
Slintak, V
Nelson, JM
Fry, DW
Bradford, L
Hallak, H
Doherty, AM
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (15) : 2296 - 2303
[2] Structure-activity relationships of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.
Connolly, CJC
Hamby, JM
Schroeder, MC
Lu, GH
Panek, L
Amar, A
Shen, C
Kraker, AJ
Doherty, AM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 193 - MEDI
[3] Design and synthesis of alkyl substituted pyridino [2,3-D]pyrimidine compounds as PI3Kα/mTOR dual inhibitors with improved pharmacokinetic properties and potent in vivo antitumor activity
Liu, Yinyin
Xia, Qinhua
Fang, Lei
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (14) : 3992 - 4000
[4] Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold
Wurz, Ryan P.
Liu, Longbin
Yang, Kevin
Nishimura, Nobuko
Bo, Yunxin
Pettus, Liping H.
Caenepeel, Sean
Freeman, Daniel J.
McCarter, John D.
Mullady, Erin L.
Miguel, Tisha San
Wang, Ling
Zhang, Nancy
Andrews, Kristin L.
Whittington, Douglas A.
Jiang, Jian
Subramanian, Raju
Hughes, Paul E.
Norman, Mark H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5714 - 5720
[5] Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure-Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives
Nishimura, Nobuko
Siegmund, Aaron
Liu, Longbin
Yang, Kevin
Bryan, Marian C.
Andrews, Kristin L.
Bo, Yunxin
Booker, Shon K.
Caenepeel, Sean
Freeman, Daniel
Liao, Hongyu
McCarter, John
Mullady, Erin L.
San Miguel, Tisha
Subramanian, Raju
Tamayo, Nuria
Wang, Ling
Whittington, Douglas A.
Zalameda, Leeanne
Zhang, Nancy
Hughes, Paul E.
Norman, Mark H.
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4735 - 4751
[6] Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors
Connolly, CJC
Hamby, JM
Schroeder, MC
Barvian, M
Lu, GH
Panek, RL
Amar, A
Shen, C
Kraker, AJ
Fry, DW
Klohs, WD
Doherty, AM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (18) : 2415 - 2420
[7] DESIGN, SYNTHESIS AND ANTITUMOR ACTIVITY OF THIOPYRANO-PYRIMIDINE COMPOUNDS AS PI3K/MTOR DUAL INHIBITORS
Wang, Q. Q.
Zhang, Z. W.
Wei, N. S.
Yu, Q. Y.
Xie, L. X.
Zheng, P. W.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 10 - 11
[8] Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2-d]Pyrimidine Series as Novel PI3K/mTOR Inhibitors
Buron, Frederic
Rodrigues, Nuno
Saurat, Thibault
Hiebel, Marie Aude
Bourg, Stephane
Bonnet, Pascal
Nehme, Reine
Morin, Philippe
Percina, Nathalie
Corret, Justine
Vallee, Beatrice
le Guevel, Remy
Jourdan, Marie-Lise
Benedetti, Helene
Routier, Sylvain
MOLECULES, 2021, 26 (17):
[9] Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists
Guo, ZQ
Chen, YS
Wu, DP
Zhu, YF
Struthers, RS
Saunders, J
Me, Q
Chen, C
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3617 - 3622
[10] Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation
Yu, Mingfeng
Li, Peng
Basnet, Sunita K. C.
Kumarasiri, Malika
Diab, Sarah
Teo, Theodosia
Albrecht, Hugo
Wang, Shudong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 95 : 116 - 126

← 1 2 3 4 5 →